22 Sep 2025 by admin in UncategorizedComments Avenzo Therapeutics Announces $60 Million Series B Financing
10 Sep 2025 by admin in UncategorizedComments Design Therapeutics Appoints Justin Gover to Board of Directors
02 Sep 2025 by admin in UncategorizedComments Zenas BioPharmand Royalty Pharma Enter into Obexelimab Funding Agrement for up to $30 Milion $300 Million
02 Sep 2025 by admin in UncategorizedComments Avenzo Therapeutics Announces FDA Clearance of Investigational New Drug Application for AVZO-103, a Potential Best-in-Class Nectin4/TROP2 Bispecific Antibody-Drug Conjugate
